Aripiprazole Accord Healthcare 10 mg tablets Irland - engelsk - HPRA (Health Products Regulatory Authority)

aripiprazole accord healthcare 10 mg tablets

accord healthcare ireland ltd. - aripiprazole - tablet - 10 milligram(s) - other antipsychotics; aripiprazole

Aripiprazole Accord Healthcare 15 mg tablets Irland - engelsk - HPRA (Health Products Regulatory Authority)

aripiprazole accord healthcare 15 mg tablets

accord healthcare ireland ltd. - aripiprazole - tablet - 15 milligram(s) - other antipsychotics; aripiprazole

Aripiprazole Accord Healthcare 30 mg tablets Irland - engelsk - HPRA (Health Products Regulatory Authority)

aripiprazole accord healthcare 30 mg tablets

accord healthcare ireland ltd. - aripiprazole - tablet - 30 milligram(s) - other antipsychotics; aripiprazole

Aripiprazole Accord Healthcare 5 mg tablets Irland - engelsk - HPRA (Health Products Regulatory Authority)

aripiprazole accord healthcare 5 mg tablets

accord healthcare ireland ltd. - aripiprazole - tablet - 5 milligram(s) - other antipsychotics; aripiprazole

KETRACCORD levetiracetam 1000 mg tablet blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

ketraccord levetiracetam 1000 mg tablet blister pack

accord healthcare pty ltd - levetiracetam, quantity: 1000 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; povidone; magnesium stearate; croscarmellose sodium; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - ketraccord tablets are indicated for: ? use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation. ? monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. ? add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme) and, ? add-on therapy in the treatment of primary generalised tonic-clonic seizures (pgtc) in adults and children from 4 years of age with idiopathic generalised epilepsy (ige).

KETRACCORD levetiracetam 500 mg tablet blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

ketraccord levetiracetam 500 mg tablet blister pack

accord healthcare pty ltd - levetiracetam, quantity: 500 mg - tablet, film coated - excipient ingredients: povidone; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - ketraccord tablets are indicated for: ? use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation. ? monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. ? add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme) and, ? add-on therapy in the treatment of primary generalised tonic-clonic seizures (pgtc) in adults and children from 4 years of age with idiopathic generalised epilepsy (ige).

KETRACCORD levetiracetam 250 mg tablet blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

ketraccord levetiracetam 250 mg tablet blister pack

accord healthcare pty ltd - levetiracetam, quantity: 250 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; povidone; colloidal anhydrous silica; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - ketraccord tablets are indicated for: ? use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation. ? monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. ? add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme) and, ? add-on therapy in the treatment of primary generalised tonic-clonic seizures (pgtc) in adults and children from 4 years of age with idiopathic generalised epilepsy (ige).

LYRACCORD Pregabalin 75 mg capsules blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

lyraccord pregabalin 75 mg capsules blister pack

accord healthcare pty ltd - pregabalin, quantity: 75 mg - capsule, hard - excipient ingredients: purified water; sodium lauryl sulfate; pregelatinised maize starch; titanium dioxide; gelatin; iron oxide red; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyraccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyraccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

LYRACCORD Pregabalin 25 mg capsules bottle pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

lyraccord pregabalin 25 mg capsules bottle pack

accord healthcare pty ltd - pregabalin, quantity: 25 mg - capsule, hard - excipient ingredients: gelatin; titanium dioxide; sodium lauryl sulfate; purified water; pregelatinised maize starch; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyraccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyraccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

LYRACCORD Pregabalin 150 mg capsules bottle pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

lyraccord pregabalin 150 mg capsules bottle pack

accord healthcare pty ltd - pregabalin, quantity: 150 mg - capsule, hard - excipient ingredients: purified water; purified talc; gelatin; titanium dioxide; sodium lauryl sulfate; pregelatinised maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyraccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyraccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.